0:00
/
0:00
Transcript

Episode 3 - Slimming Madness

The truth about GLP-1 Agonist Weight Loss Drugs (Ozempic, Wegovy, Mounjaro)

In this episode, we talk a little technical and summarise:

·      The major hormones involved in regulating blood sugar and metabolism

·      The original semaglutide SUSTAIN Phase 3 trial in diabetes patients and its expansion to use for weight loss

·      The general mechanisms of GLP-1 inhibitors

·      Why discontinuing medicine long-term can be desirable for non-diabetics and what happens after

Links:

https://zatonski.substack.com/p/glp-1s-for-weight-loss?utm_source=publication-search

https://dom-pubs.onlinelibrary.wiley.com/doi/epdf/10.1111/dom.14725

https://pmc.ncbi.nlm.nih.gov/articles/PMC7064975/

Disclaimer: The content of this podcast/blog is provided for general informational purposes only. It is not intended as medical, nursing, or other professional healthcare advice, nor does it create a doctor-patient relationship. Any use of the information on this blog, or materials linked from it, is at the reader's own risk. This blog's content is not a replacement for professional medical advice, diagnosis, or treatment. Readers and listeners should not ignore or postpone seeking medical advice for any health condition and are encouraged to consult their healthcare professionals for proper guidance

Discussion about this podcast